Update on and future perspectives for the diagnosis of alpha-1 antitrypsin deficiency in Brazil
ABSTRACT Alpha-1 antitrypsin deficiency (AATD) is a rare genetic disorder caused by a mutation in the SERPINA1 gene, which encodes the protease inhibitor alpha-1 antitrypsin (AAT). Severe AATD predisposes individuals to COPD and liver disease. Early diagnosis is essential for implementing preventive measures and limiting the disease burden. Although national and international guidelines for the diagnosis and management of AATD have been available for 20 years, more than 85% of cases go undiagnosed and therefore untreated. In Brazil, reasons for the underdiagnosis of AATD include a lack of awareness of the condition among physicians, a racially diverse population, serum AAT levels being assessed in a limited number of individuals, and lack of convenient diagnostic tools. The diagnosis of AATD is based on laboratory test results. The standard diagnostic approach involves the assessment of serum AAT levels, followed by phenotyping, genotyping, gene sequencing, or combinations of those, to detect the specific mutation. Over the past 10 years, new techniques have been developed, offering a rapid, minimally invasive, reliable alternative to traditional testing methods. One such test available in Brazil is the A1AT Genotyping Test, which simultaneously analyzes the 14 most prevalent AATD mutations, using DNA extracted from a buccal swab or dried blood spot. Such advances may contribute to overcoming the problem of underdiagnosis in Brazil and elsewhere, as well as being likely to increase the rate detection of AATD and therefore mitigate the harmful effects of delayed diagnosis.
Main Authors: | , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Brasileira de Pneumologia e Tisiologia
2021
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132021000300501 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S1806-37132021000300501 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S1806-371320210003005012021-05-28Update on and future perspectives for the diagnosis of alpha-1 antitrypsin deficiency in BrazilJardim,José RCasas-Maldonado,FranciscoFernandes,Frederico Leon ArrabalCastellano,Maria Vera Cruz de OTorres-Durán,MaríaMiravitlles,Marc alpha 1-antitrypsin deficiency/diagnosis alpha 1-antitrypsin deficiency/genetics Genotyping techniques ABSTRACT Alpha-1 antitrypsin deficiency (AATD) is a rare genetic disorder caused by a mutation in the SERPINA1 gene, which encodes the protease inhibitor alpha-1 antitrypsin (AAT). Severe AATD predisposes individuals to COPD and liver disease. Early diagnosis is essential for implementing preventive measures and limiting the disease burden. Although national and international guidelines for the diagnosis and management of AATD have been available for 20 years, more than 85% of cases go undiagnosed and therefore untreated. In Brazil, reasons for the underdiagnosis of AATD include a lack of awareness of the condition among physicians, a racially diverse population, serum AAT levels being assessed in a limited number of individuals, and lack of convenient diagnostic tools. The diagnosis of AATD is based on laboratory test results. The standard diagnostic approach involves the assessment of serum AAT levels, followed by phenotyping, genotyping, gene sequencing, or combinations of those, to detect the specific mutation. Over the past 10 years, new techniques have been developed, offering a rapid, minimally invasive, reliable alternative to traditional testing methods. One such test available in Brazil is the A1AT Genotyping Test, which simultaneously analyzes the 14 most prevalent AATD mutations, using DNA extracted from a buccal swab or dried blood spot. Such advances may contribute to overcoming the problem of underdiagnosis in Brazil and elsewhere, as well as being likely to increase the rate detection of AATD and therefore mitigate the harmful effects of delayed diagnosis.info:eu-repo/semantics/openAccessSociedade Brasileira de Pneumologia e TisiologiaJornal Brasileiro de Pneumologia v.47 n.3 20212021-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132021000300501en10.36416/1806-3756/e20200380 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Jardim,José R Casas-Maldonado,Francisco Fernandes,Frederico Leon Arrabal Castellano,Maria Vera Cruz de O Torres-Durán,María Miravitlles,Marc |
spellingShingle |
Jardim,José R Casas-Maldonado,Francisco Fernandes,Frederico Leon Arrabal Castellano,Maria Vera Cruz de O Torres-Durán,María Miravitlles,Marc Update on and future perspectives for the diagnosis of alpha-1 antitrypsin deficiency in Brazil |
author_facet |
Jardim,José R Casas-Maldonado,Francisco Fernandes,Frederico Leon Arrabal Castellano,Maria Vera Cruz de O Torres-Durán,María Miravitlles,Marc |
author_sort |
Jardim,José R |
title |
Update on and future perspectives for the diagnosis of alpha-1 antitrypsin deficiency in Brazil |
title_short |
Update on and future perspectives for the diagnosis of alpha-1 antitrypsin deficiency in Brazil |
title_full |
Update on and future perspectives for the diagnosis of alpha-1 antitrypsin deficiency in Brazil |
title_fullStr |
Update on and future perspectives for the diagnosis of alpha-1 antitrypsin deficiency in Brazil |
title_full_unstemmed |
Update on and future perspectives for the diagnosis of alpha-1 antitrypsin deficiency in Brazil |
title_sort |
update on and future perspectives for the diagnosis of alpha-1 antitrypsin deficiency in brazil |
description |
ABSTRACT Alpha-1 antitrypsin deficiency (AATD) is a rare genetic disorder caused by a mutation in the SERPINA1 gene, which encodes the protease inhibitor alpha-1 antitrypsin (AAT). Severe AATD predisposes individuals to COPD and liver disease. Early diagnosis is essential for implementing preventive measures and limiting the disease burden. Although national and international guidelines for the diagnosis and management of AATD have been available for 20 years, more than 85% of cases go undiagnosed and therefore untreated. In Brazil, reasons for the underdiagnosis of AATD include a lack of awareness of the condition among physicians, a racially diverse population, serum AAT levels being assessed in a limited number of individuals, and lack of convenient diagnostic tools. The diagnosis of AATD is based on laboratory test results. The standard diagnostic approach involves the assessment of serum AAT levels, followed by phenotyping, genotyping, gene sequencing, or combinations of those, to detect the specific mutation. Over the past 10 years, new techniques have been developed, offering a rapid, minimally invasive, reliable alternative to traditional testing methods. One such test available in Brazil is the A1AT Genotyping Test, which simultaneously analyzes the 14 most prevalent AATD mutations, using DNA extracted from a buccal swab or dried blood spot. Such advances may contribute to overcoming the problem of underdiagnosis in Brazil and elsewhere, as well as being likely to increase the rate detection of AATD and therefore mitigate the harmful effects of delayed diagnosis. |
publisher |
Sociedade Brasileira de Pneumologia e Tisiologia |
publishDate |
2021 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132021000300501 |
work_keys_str_mv |
AT jardimjoser updateonandfutureperspectivesforthediagnosisofalpha1antitrypsindeficiencyinbrazil AT casasmaldonadofrancisco updateonandfutureperspectivesforthediagnosisofalpha1antitrypsindeficiencyinbrazil AT fernandesfredericoleonarrabal updateonandfutureperspectivesforthediagnosisofalpha1antitrypsindeficiencyinbrazil AT castellanomariaveracruzdeo updateonandfutureperspectivesforthediagnosisofalpha1antitrypsindeficiencyinbrazil AT torresduranmaria updateonandfutureperspectivesforthediagnosisofalpha1antitrypsindeficiencyinbrazil AT miravitllesmarc updateonandfutureperspectivesforthediagnosisofalpha1antitrypsindeficiencyinbrazil |
_version_ |
1756431159712022528 |